News

  • Type of News:

  • June 5, 2020

    AAV COVID-19 vaccine aims for the sweet spot between antibody and T cell immunity

  • May 29, 2020

    Coronavirus vaccine: Merck and Novartis join the hunt for a COVID-19 vaccine

  • May 28, 2020

    Novartis to make U.S. researchers' COVID-19 gene therapy vaccine hopeful

  • May 28, 2020

    Novartis zal gratis testvaccins van Belg in VS produceren

  • May 28, 2020

    Novartis Inks Deal to Make Experimental Coronavirus Vaccine

  • May 28, 2020

    Big gene therapy names line up behind experimental Covid-19 vaccine

  • May 25, 2020

    Nerea Zabaleta: "Txerto bat baino gehiago izatea litzateke onena"

  • May 7, 2020

    COVID-19 : la thérapie génique, nouvelle piste envisagée pour un vaccin

  • May 4, 2020

    Harvard-affiliated hospitals launch new effort to make coronavirus vaccine, with help from Celtics co-owner

  • May 4, 2020

    A Coronavirus Vaccine Project Takes a Page From Gene Therapy

  • May 4, 2020

    COVID-19 Vaccine Development Fund

  • November 13, 2019

    Researchers Uncover Mechanism for How Common Gene Therapy Vectors Enter Cells

  • March 15, 2019

    Luk H. Vandenberghe, PhD, Named Grousbeck Family Chair in Gene Therapy at Mass. Eye and Ear

  • March 4, 2019

    A review in the March 6 issue of Neuron by Drs Hudry (MGH) and Vandenberghe makes it to the cover: Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality

  • February 1, 2019

    Anna Maurer graduates from Harvard’s Biological and Biomedical Sciences Grad program with her work on AAV assembly. Anna is staying on as a postdoc for a short period before moving on to Robert Tjian’s lab at Berkeley.

  • January 22, 2019

    Thank you for the mention of our work on gene delivery for hearing disorders in Proto, the publication on research from Mass General!

  • January 10, 2019

    Congratulations Anna Maurer and Ana-Karla Cepeda on their Journal of Virology paper from the lab on the docking side of AAP on the AAV capsid.

  • January 2, 2019

    Nerea Zabalenta Lasarte, PhD joins the lab from the University of Navarra where she worked on liver-directed gene and genome editing therapies in the lab of Gloria González-Aseguinolaza.

  • December 12, 2018

    Our lab’s research and Dr. Vandenberghe are spotlighted in Nature!

  • December 6, 2018

    Congratulations to our collaborators at NIGRI (NIH) for their publication in JCI Insight on our joint work on gene therapy for Methylmalonic Acidemia

  • September 2, 2018

    Amanda Dudek graduates from the Harvard Virology Graduate Program on her work on AAV entry factors. Congratulations Amanda!

  • March 22, 2017

    A step toward the prospect of cochlear gene therapy with our reports in Nature Biotech on Anc80's unique targeting of Outer Hair Cells in the inner ear

© 2018 Grousbeck Gene Therapy Center

20 Staniford Street, Boston, MA 02114